PortfoliosLab logoPortfoliosLab logo
TGTX vs. OGC.TO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TGTX vs. OGC.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TG Therapeutics, Inc. (TGTX) and OceanaGold Corporation (OGC.TO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

TGTX is traded in USD, while OGC.TO is traded in CAD. To make them comparable, the OGC.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, TGTX achieves a 91.61% return, which is significantly higher than OGC.TO's -12.51% return. Over the past 10 years, TGTX has outperformed OGC.TO with an annualized return of 24.86%, while OGC.TO has yielded a comparatively lower 7.85% annualized return.


TGTX

1D
-3.28%
1M
18.88%
6M
100.63%
YTD
91.61%
1Y
54.02%
3Y*
31.01%
5Y*
7.20%
10Y*
24.86%

OGC.TO

1D
-0.62%
1M
-2.03%
6M
-18.41%
YTD
-12.51%
1Y
74.32%
3Y*
62.25%
5Y*
34.79%
10Y*
7.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TGTX vs. OGC.TO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TGTX
TG Therapeutics, Inc.
91.61%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%
OGC.TO
OceanaGold Corporation
-12.51%243.14%44.90%1.19%10.28%-10.52%-1.18%-46.54%42.71%-11.18%

Correlation

The correlation between TGTX and OGC.TO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.04

Fundamentals

Market Cap

TGTX:

$8.74B

OGC.TO:

CA$7.83B

EPS

TGTX:

$2.88

OGC.TO:

$1.94

PE Ratio

TGTX:

19.80

OGC.TO:

12.74

PEG Ratio

TGTX:

0.03

OGC.TO:

0.03

PS Ratio

TGTX:

13.06

OGC.TO:

4.30

PB Ratio

TGTX:

15.68

OGC.TO:

2.34

Total Revenue (TTM)

TGTX:

$700.35M

OGC.TO:

$2.25B

Gross Profit (TTM)

TGTX:

$581.54M

OGC.TO:

$1.24B

EBITDA (TTM)

TGTX:

$156.88M

OGC.TO:

$1.22B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TGTX vs. OGC.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TGTX
TGTX Risk / Return Rank: 7575
Overall Rank
TGTX Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 7575
Sortino Ratio Rank
TGTX Omega Ratio Rank: 7575
Omega Ratio Rank
TGTX Calmar Ratio Rank: 7474
Calmar Ratio Rank
TGTX Martin Ratio Rank: 7171
Martin Ratio Rank

OGC.TO
OGC.TO Risk / Return Rank: 8181
Overall Rank
OGC.TO Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
OGC.TO Sortino Ratio Rank: 8080
Sortino Ratio Rank
OGC.TO Omega Ratio Rank: 7979
Omega Ratio Rank
OGC.TO Calmar Ratio Rank: 7979
Calmar Ratio Rank
OGC.TO Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TGTX vs. OGC.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and OceanaGold Corporation (OGC.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TGTXOGC.TODifference
Sharpe ratioReturn per unit of total volatility

-0.37

Sortino ratioReturn per unit of downside risk

-0.15

Omega ratioGain probability vs. loss probability

1.23

1.24

-0.02

Calmar ratioReturn relative to maximum drawdown

1.59

1.78

-0.19

Martin ratioReturn relative to average drawdown

2.87

4.18

-1.31

TGTX vs. OGC.TO - Sharpe Ratio Comparison

The current TGTX Sharpe Ratio is 1.10, which is comparable to the OGC.TO Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of TGTX and OGC.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TGTX vs. OGC.TO - Drawdown Comparison

The maximum TGTX drawdown since its inception was -99.52%, roughly equal to the maximum OGC.TO drawdown of -97.03%. Use the drawdown chart below to compare losses from any high point for TGTX and OGC.TO.


Loading charts...

Drawdown Indicators


TGTXOGC.TODifference

Max Drawdown

Largest peak-to-trough decline

-99.52%

-97.03%

-2.49%

Max Drawdown (1Y)

Largest decline over 1 year

-32.66%

-43.27%

+10.61%

Max Drawdown (3Y)

Largest decline over 3 years

-69.77%

-43.27%

-26.50%

Max Drawdown (5Y)

Largest decline over 5 years

-90.34%

-49.76%

-40.58%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

-78.65%

-14.54%

Current Drawdown

Current decline from peak

-75.53%

-41.60%

-33.93%

Average Drawdown

Average peak-to-trough decline

-91.36%

-41.50%

-49.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.01%

18.39%

-0.38%

Volatility

TGTX vs. OGC.TO - Volatility Comparison

The current volatility for TG Therapeutics, Inc. (TGTX) is 12.22%, while OceanaGold Corporation (OGC.TO) has a volatility of 15.47%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than OGC.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TGTXOGC.TODifference

Volatility (1M)

Calculated over the trailing 1-month period

12.22%

15.47%

-3.25%

Volatility (6M)

Calculated over the trailing 6-month period

34.37%

42.36%

-7.99%

Volatility (1Y)

Calculated over the trailing 1-year period

47.15%

52.48%

-5.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.77%

50.44%

+37.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.78%

53.11%

+33.67%

Dividends

TGTX vs. OGC.TO - Dividend Comparison

TGTX has not paid dividends to shareholders, while OGC.TO's dividend yield for the trailing twelve months is around 0.94%.


PositionTTM20252024202320222021202020192018201720162015
OGC.TO
OceanaGold Corporation
0.94%0.29%0.23%0.36%0.00%0.00%0.00%0.18%0.26%0.27%0.46%0.63%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TGTX vs. OGC.TO - Financials Comparison

This section allows you to compare key financial metrics between TG Therapeutics, Inc. and OceanaGold Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
204.92M
702.79M
(TGTX) Total Revenue
(OGC.TO) Total Revenue
Values in USD except per share items

TGTX vs. OGC.TO - Profitability Comparison

The chart below illustrates the profitability comparison between TG Therapeutics, Inc. and OceanaGold Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
83.7%
56.5%
Portfolio components
TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

OGC.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported a gross profit of 397.08M and revenue of 702.79M. Therefore, the gross margin over that period was 56.5%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

OGC.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported an operating income of 330.79M and revenue of 702.79M, resulting in an operating margin of 47.1%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.

OGC.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported a net income of 224.66M and revenue of 702.79M, resulting in a net margin of 32.0%.


Frequently Asked Questions


TGTX and OGC.TO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for TGTX and OGC.TO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer